Eltoprazine

1 stories · following the connections

Business

Elto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive Impairment

By Nasdaq OMXMay 1, 2018, 2:31 PM UTC